Category - Latest Science

GHP News Latest Science

Vaccine manufacturer news

Western Companies Moderna (UK). Moderna has opened a new mRNA vaccine manufacturing facility in Oxfordshire, UK, with the capacity to produce approximately 100 million doses annually under steady-state conditions...

2 October, 2025

2 min read

GHP News Latest Science

Vaccine manufacturer
news briefing
(updated September 22, 2025)

South Africa — Biovac (WHO mRNA hub) Sept 2025 — The Biovac Institute (South Africa) is scaling mRNA manufacturing capacity as a core partner of WHO’s mRNA Technology Transfer Programme, with roles spanning technology...

24 September, 2025

2 min read

GHP News Latest Science

Shall we invest in research on HIV, tuberculosis and malaria?

This study presents a rigorous global modelling analysis of optimal investment strategies to combat HIV, tuberculosis (TB), and malaria in the context of the Sustainable Development Goals, focusing on the portfolio of...

24 September, 2025

4 min read

GHP News Latest Science

Data manipulation by the US government

This article investigates recent data manipulation practices within U.S. federal health datasets, focusing on the systematic replacement of the term “gender” with “sex” between January and March 2025. The authors...

24 September, 2025

3 min read

GHP News Latest Science

COVID-19 vaccine safety in pregnant and non-pregnant women

This population-based, exposure-matched cohort study assessed the incidence of medically attended adverse events following COVID-19 vaccination and SARS-CoV-2 infection in over one million pregnant and non-pregnant...

24 September, 2025

3 min read

GHP News Latest Science

Dynamics of influenzas vaccine induced antibodies – what can we learn?

Lane A, Quach HQ, Ovsyannikova IG, Kennedy RB, Ross TM, Einav T. High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across...

16 September, 2025

3 min read

GHP News Latest Science

US government drastically reduces mRNA vaccine research funding

Petersen E, Ippolito G, Maeurer M, Ntoumi F, Nachega JB, Hui DS, Zumla A. Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine research. Lancet Microbe. Published online August 2025...

16 September, 2025

4 min read

GHP News Latest Science

Measles outbreak in Sudan

Azhary A, Hajhamed NM, Osman Ali ET, Muvunyi CM, Siddig EE. Resurgent multistate measles outbreak in Sudan amidst conflict: Urgent need for vaccination and international support. Int J Infect Dis. 2025. doi:10.1016/j...

16 September, 2025

3 min read

GHP News Latest Science

Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections

This prospective pilot study assessed the real-time epidemiology of acute respiratory infections (ARI) in Germany using self-administered, multi-pathogen antigen rapid testing among adult volunteers from the VACCELERATE...

9 September, 2025

3 min read

GHP News Latest Science

RSV prefusion F vaccine for prevention of hospitalization in older adults

The DAN-RSV phase 4 pragmatic randomized trial evaluated the effectiveness and safety of the bivalent RSV prefusion F protein–based vaccine (RSVpreF) in adults aged 60 years and older during the 2024–2025 season in...

9 September, 2025

2 min read